EWSR1 antibody
Quick Overview for EWSR1 antibody (ABIN7247048)
Target
See all EWSR1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Characteristics
- Polyclonal Antibody
- 
                                            Purification
- Antigen affinity purification
- 
                                            Immunogen
- Fusion protein of human EWSR1
- 
                                            Isotype
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- WB 1:1000-1:5000, IHC 1:50-1:300, ELISA 1:5000-1:10000
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Concentration
- 1.26 mg/mL
- 
                                            Buffer
- PBS with 0.05 % Sodium azide and 40 % Glycerol, pH 7.4
- 
                                            Preservative
- Sodium azide
- 
                                            Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Storage
- -20 °C
- 
                                            Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
 
- 
                                            
- 
    - EWSR1 (Ewing Sarcoma Breakpoint Region 1 (EWSR1))
- 
                                            Alternative Name
- EWSR1
- 
                                            Background
- This gene encodes a multifunctional protein that is involved in various cellular processes, including gene expression, cell signaling, and RNA processing and transport. The protein includes an N-terminal transcriptional activation domain and a C-terminal RNA-binding domain. Chromosomal translocations between this gene and various genes encoding transcription factors result in the production of chimeric proteins that are involved in tumorigenesis. These chimeric proteins usually consist of the N-terminal transcriptional activation domain of this protein fused to the C-terminal DNA-binding domain of the transcription factor protein. Mutations in this gene, specifically a t(11,22)(q24,q12) translocation, are known to cause Ewing sarcoma as well as neuroectodermal and various other tumors. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 1 and 14.
- 
                                            Molecular Weight
- 
                        Observed_MW: Refer to figures Calculated_MW: 68 kDa 
- 
                                            UniProt
- Q01844
 Target
- 
                    
 
                                     
                                     
                                    